Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PCC Rokita's Other Operating Expense for the
three
months ended in Mar. 2026 was zł-1 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was zł-68 Mil.
PCC Rokita's quarterly Other Operating Expense
increased
from Sep. 2025 (zł-46 Mil) to Dec. 2025 (zł-20 Mil) and
increased
from Dec. 2025 (zł-20 Mil) to Mar. 2026 (zł-1 Mil).
PCC Rokita's annual Other Operating Expense
increased
from Dec. 2023 (zł-83 Mil) to Dec. 2024 (zł-81 Mil) and
increased
from Dec. 2024 (zł-81 Mil) to Dec. 2025 (zł-62 Mil).
PCC Rokita Other Operating Expense Related Terms
PCC Rokita Other Operating Expense Historical Data
* Premium members only.
The historical data trend for PCC Rokita's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-68 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of zł-68 Mil mean?
PCC Rokita (WAR:PCR) has a Other Operating Expense of zł-68 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on PCC Rokita and its competitors.
Is PCC Rokita's Other Operating Expense too high?
PCC Rokita's current Other Operating Expense is zł-68 Mil. Overall, PCC Rokita has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PCC Rokita's Other Operating Expense compare to DOW?
PCC Rokita's Other Operating Expense of zł-68 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Chemicals company?
A good Other Operating Expense depends on the Chemicals industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on PCC Rokita and its competitors. PCC Rokita's current Other Operating Expense is zł-68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PCC Rokita stock overvalued right now?
Based on GuruFocus' analysis, PCC Rokita (WAR:PCR) is currently considered Fairly Valued. The stock's GF Value™ is zł66.24, compared to a current price of zł69.50 — trading 4.9% above its estimated fair value. The current Other Operating Expense is zł-68 Mil. PCC Rokita's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For PCC Rokita (WAR:PCR), the current Other Operating Expense is zł-68 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PCC Rokita (WAR:PCR) Overvalued in 2026?
Based on GuruFocus' analysis, PCC Rokita stock appears to be overvalued.
The current stock price of zł69.50 is trading 4.9% above its estimated GF Value™ of zł66.24.
GuruFocus considers PCC Rokita to be Fairly Valued.
Key valuation signals for WAR:PCR:
Other Operating Expense: zł-68 Mil
GF Value™: zł66.24 vs. price of zł69.50 (4.9% above fair value)
No single metric tells the full story. See the WAR:PCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PCC Rokita SA is engaged in manufacturing chemicals. Its products include Polyols, Chloralkali, Chlorobenzene, Phosphorus derivatives, and Naphthalene derivatives. It serves adhesives, agrochemicals, building and construction, case, detergents, fire prevention, food and fuel industry, furniture, I&I cleaning, lubricants and functional fluids, metallurgical, mining and drilling, oilfield, paints and coatings, personal care, pharmaceuticals, plastics, power, printing ink, pulp and paper, raw materials and intermediates, refrigeration and household appliances, sports and recreation, tanning and textile, transportation, and water and wastewater treatment industries.
82GF Score
Get the complete analysis for WAR:PCR
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PCR has been successfully added to your 
